| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |